Overcoming acquired resistance to cetuximab by dual targeting HER family receptors with antibody-based therapy
2014 · Molecular Cancer · 64 citations
https://doi.org/10.1186/1476-4598-13-242
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
10
Papers
460
Citations
5
h-index
5
i10-index
Megan M. Starr is an academic researcher from University of Wisconsin–Madison. The author has contributed to research in topics: HER2/EGFR in Cancer Research & Monoclonal and Polyclonal Antibodies Research & Lung Cancer Treatments and Mutations. The author has an h-index of 5, co-authored 9 publications.
Click to start Chat